A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)

NCT07408232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

DRUG: Phase 1a: OCT-980 Capsule
DRUG: Phase 1a: Placebo Capsule
DRUG: Phase 1b/2: OCT-980 Tablet

Sponsor

Octant, Inc.